The Aidspan Guide to Applications under the Global Fund's Transitional Funding Mechanism

Published: January 10, 2012

Table of Contents

Preface ………………………………………………………………………………………………………. 5

List of Abbreviations and Acronyms ……………………………………………………………. 7

Chapter 1: Introduction ……………………………………………………………………………….. 8
Purpose of This Guide ………………………………………………………………………………………….. 8
Terminology Used in This Guide …………………………………………………………………………….. 8
Contents of This Guide …………………………………………………………………………………………. 9

Chapter 2: What’s New for Applications under the TFM? ……………………………. 11
Who is Eligible to Apply under the TFM? ………………………………………………………………… 11
Technical eligibility ……………………………………………………………………………………………………….. 11
Additional criteria specific to the TFM ……………………………………………………………………………… 12
Functioning of the coordinating mechanism and the proposal development process …………….. 14
Counterpart financing ……………………………………………………………………………………………………. 15
Duration of Funding…………………………………………………………………………………………….. 17
Two Pools of Funding …………………………………………………………………………………………. 17
Prioritisation ………………………………………………………………………………………………………. 18
Re-programming ………………………………………………………………………………………………… 18
Health Systems Strengthening ……………………………………………………………………………… 19
Consolidated Proposals Mandatory for Some Applicants ………………………………………….. 19
Single-Stream-of-Funding Agreements and Grant Consolidation ……………………………….. 19
Changes to the Proposal Form and Guidelines ……………………………………………………….. 19
Other Changes …………………………………………………………………………………………………… 20

Chapter 3: General Information on the TFM Applications Process ………………. 21
Guidelines for Proposals ……………………………………………………………………………………… 21
Funding Available for the TFM ……………………………………………………………………………… 21
Eligibility Criteria and Counterpart Financing Requirements ………………………………………. 21
Information Notes and FAQs ………………………………………………………………………………… 22
Versions of the Proposal Form ……………………………………………………………………………… 24
Documents that Form Part of Your Application ………………………………………………………… 25
Process for Submitting a Proposal ………………………………………………………………………… 26
The TRP Review ………………………………………………………………………………………………… 27
Some Key Concepts Used in All Proposals …………………………………………………………….. 28
General Guidance on Filling out the Proposal Form …………………………………………………. 29

Chapter 4: Guidance on Specific Sections of the TFM Proposal Form …………. 30

SECTION 1: APPLICANT INFORMATION AND FUNDING SUMMARY ……………………… 31
1.1 Applicant Name and Country Information ……………………………………………………………………….. 31
1.2 Component/s and Choice of Funding Pool ……………………………………………………………………… 31
1.3 Information on Continuity of Services (CoS) Request ………………………………………………………. 31
1.4 TFM Funding Summary ……………………………………………………………………………………………….. 32
1.5 Contact Details ……………………………………………………………………………………………………………. 32
1.6 List of Abbreviations and Acronyms Used by the Applicant ………………………………………………. 32

SECTION 2: REQUIREMENTS FOR ELIGIBILITY ………………………………………………….. 33
2.1 Proposal Development Process …………………………………………………………………………………….. 34
2.2 Process to Select Principal Recipients …………………………………………………………………………… 34
2.3 Non-implementation of Dual Track Financing ………………………………………………………………….. 36
2.4 Process to Oversee Program Implementation …………………………………………………………………. 37
2.5 Broad and Inclusive Membership …………………………………………………………………………………… 38
2.6 Managing Conflict of Interest ………………………………………………………………………………………… 38
2.7 Proposal Endorsement by Members ………………………………………………………………………………. 38
2.8 Status of Sub-CCM ……………………………………………………………………………………………………… 39
2.9 CCM Endorsement ………………………………………………………………………………………………………. 39
2.10 Justification of Independence of Sub-CCM …………………………………………………………………… 39
2.11 Sector of Work ………………………………………………………………………………………………………….. 40
2.12 Justification for Non-CCM Proposal ……………………………………………………………………………… 40
2.13 Name the Principal Recipient(s) Nominated for Your Proposal(s) ……………………………………. 40
2.14 Non-Implementation of Dual Track Financing ……………………………………………………………….. 40
2.15 Signature by Authorized Representative of Non-CCM Applicant ……………………………………… 40

SECTION 3: COUNTRY CONTEXT ……………………………………………………………………… 41
3.1 Essential Services Within the Disease Program ………………………………………………………………. 41
3.2 Epidemiological Profile of Target Populations …………………………………………………………………. 41

SECTION 4: TFM REQUEST SUMMARY ………………………………………………………………. 42
4.1 Narrative Description of TFM Request……………………………………………………………………………. 42
4.2 TFM Request in the Context of a Consolidated Application ………………………………………………. 43
4.3 Ability to Finance Through Reprogramming of Existing Global Fund Grants ……………………….. 44
4.4 Other Sources of Funding …………………………………………………………………………………………….. 44

SECTION 5: MONITORING AND EVALUATION …………………………………………………….. 45
5.1 Performance Framework ……………………………………………………………………………………………… 45
5.2 (a) Impact and Outcome Measurement ………………………………………………………………………….. 45
5.2 (b) Program Evaluations ………………………………………………………………………………………………. 46

SECTION 6: PHARMACEUTICAL AND OTHER HEALTH PRODUCTS ……………………… 47
6.1 Management of Pharmaceutical and Health Product Activities ………………………………………….. 47
6.2 Pharmaceutical and Health Products Required for Continuation of Essential Prevention and Treatment Services ………………………………………………………………………………………………………………. 48
6.3 Multi-Drug Resistant Tuberculosis …………………………………………………………………………………. 48

SECTION 7: FUNDING REQUEST……………………………………………………………………….. 49
7.1 Financial Gap Analysis and Counterpart Financing Calculation …………………………………………. 49
7.2 Estimation of Current and Anticipated Domestic and External Funding ………………………………. 49
7.3 Compliance with the Counterpart Financing Requirements ………………………………………………. 50
7.4 Financial Gap and Counterpart Financing Data Sources ………………………………………………….. 51
7.5 Detailed Budget and Work Plan …………………………………………………………………………………….. 51
7.6 Summary and Incremental Request Tables ……………………………………………………………………. 52
7.7 Compliance with Focus of Proposal Requirement ……………………………………………………………. 52
SECTION 8: MANAGEMENT STRATEGIES ………………………………………………………….. 53
8.1 Principal Recipient(s) …………………………………………………………………………………………………… 53
8.2 Sub-Recipients ……………………………………………………………………………………………………………. 55

Chapter 5: Guidance on the Attachments …………………………………………………… 57
Introduction ……………………………………………………………………………………………………….. 57
Attachment A – Performance Framework ……………………………………………………………….. 57
Attachment B – List of Pharmaceutical and Health Products ……………………………………… 59
Attachment C – Membership Details of Coordinating Mechanisms …………………………….. 59
Attachment D – Logframe ……………………………………………………………………………………. 60
Attachment E – Budget, work plan and related tables ………………………………………………. 62
Attachment F – Budget-related tables ……………………………………………………………………. 62

Full text of article available at link below –

Leave a Reply